PG
KITE

PEAK6 Group’s Kite Pharma, Inc. KITE Stock Holding History

PEAK6 Group’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-30,000
Closed -$5.39M – 5239
2017
Q3 		$5.39M Buy
30,000
+10,800
+56% +$1.5M 0.03% 709
2017
Q2 		$1.99M Buy
19,200
+13,000
+210% +$1.06M 0.01% 1358
2017
Q1 		$487K Buy
+6,200
New +$383K ﹤0.01% 2279
2016
Q3 		– Sell
-2,600
Closed -$130K – 5020
2016
Q2 		$130K Sell
2,600
-12,400
-83% -$609K ﹤0.01% 3425
2016
Q1 		$689K Buy
15,000
+9,900
+194% +$480K 0.01% 1996
2015
Q4 		$314K Sell
5,100
-9,500
-65% -$669K ﹤0.01% 3024
2015
Q3 		$813K Buy
14,600
+8,400
+135% +$528K ﹤0.01% 2418
2015
Q2 		$378K Sell
6,200
-5,800
-48% -$331K ﹤0.01% 3064
2015
Q1 		$692K Buy
+12,000
New +$804K 0.01% 2247

PEAK6 Group's KITE Position: Q4 2017 in Review

PEAK6 Group sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 22,680 shares — an estimated $4.08M sold.

PEAK6 Group first reported a position in KITE in Q4 2015 and held it in 3 quarters. The position peaked at $4.08M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • PEAK6 Group reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • PEAK6 Group sold 22,680 Kite Pharma, Inc. shares in Q4 2017, an estimated $4.08M.
  • PEAK6 Group first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 3 quarters.
  • PEAK6 Group's Kite Pharma, Inc. position peaked at $4.08M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.